The critical situation posed by the COVID-19 coronavirus among high-risk individuals and the vulnerability of the earth's 7.9 billion human population to a newly mutated COVID-19 coronavirus without a proven vaccine has prompted Moshe Shifrine PhD  to pose a revolutionary therapy based upon his decades of research in the field of olfactory (smell) therapy.

Dr. Shifrine holds two patents on the use of odors to tickle the olfactory bulb in the nose to produce hormones like testosterone and insulin.  Dr. Shifrine writes:

"Just a small number of molecules (in a concentration in billionths of a gram) in the nasal passages are needed to carry scent to the 20,000 nerve receptors in the olfactory bulb that is located on both hemispheres of the forebrain.  When the molecules attach to these receptors their vibratory signature sends an electric signal to the hypothalamus in the brain that results in the production of the smelled substance.  For example, the scent of testosterone or insulin stimulates the body's production of these hormones."

Dr. Shifrine instructs:  The olfactory system is able to distinguish 12,000 different aromas.

Dr. Shifrine holds a patent (US 8,679,507 B2) for the use of truffle extract that contains a very small amount of natural testosterone. A whiff of same has been demonstrated to double testosterone levels in men in all ten subjects tested.  The truffle extract, available commercially, also elevates testosterone levels in females and was demonstrated to alleviate common symptoms of menopause.